Clear Creek Financial Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Sell
15,209
-6
-0% -$791 0.12% 174
2026
Q1
$2.12M Buy
15,215
+109
+0.7% +$15.3K 0.16% 142
2025
Q4
$1.85M Buy
15,106
+205
+1% +$24.9K 0.15% 143
2025
Q3
$1.65M Buy
14,901
+278
+2% +$31.6K 0.14% 143
2025
Q2
$1.62M Buy
14,623
+1,422
+11% +$151K 0.15% 151
2025
Q1
$1.48M Buy
13,201
+499
+4% +$51.5K 0.15% 141
2024
Q4
$1.17M Buy
+12,702
New +$1.14M 0.13% 163
2022
Q3
Sell
-3,276
Closed -$202K 297
2022
Q2
$202K Buy
+3,276
New +$203K 0.04% 280

Other funds holding GILD

Clear Creek Financial Management's GILD Position: Q2 2026 in Review

Clear Creek Financial Management reduced its Gilead Sciences (GILD) stake by 0.04% in Q2 2026, selling an estimated $791 and leaving 15,209 shares worth $1.92M. The position accounts for 0.12% of the portfolio, ranked #174.

Clear Creek Financial Management first reported a position in GILD in Q2 2022 and has held it in 8 quarters since. The position peaked at $2.12M in Q1 2026. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Clear Creek Financial Management held 15,209 shares of Gilead Sciences worth $1.92M as of Q2 2026.
  • Clear Creek Financial Management sold 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.12% of Clear Creek Financial Management's portfolio in Q2 2026, its #174 holding.
  • Clear Creek Financial Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 8 quarters since.
  • Clear Creek Financial Management's Gilead Sciences position peaked at $2.12M in Q1 2026.
  • 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.